Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: BMJ Publishing Group 2022-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/10/3/e001931corr2.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850203674150699008
collection DOAJ
format Article
id doaj-art-d2c166b88c27487caa7acd6b51ec7054
institution OA Journals
issn 2051-1426
language English
publishDate 2022-03-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-d2c166b88c27487caa7acd6b51ec70542025-08-20T02:11:26ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262022-03-0110310.1136/jitc-2020-001931corr2Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibitionhttps://jitc.bmj.com/content/10/3/e001931corr2.full
spellingShingle Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Journal for ImmunoTherapy of Cancer
title Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
title_full Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
title_fullStr Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
title_full_unstemmed Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
title_short Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
title_sort correction clinical impact of covid 19 on patients with cancer treated with immune checkpoint inhibition
url https://jitc.bmj.com/content/10/3/e001931corr2.full